2019 American Transplant Congress
Five Years after Right Hepatectomy for Living Liver Donation: Donor State of Health
General, Visceral and Transplantation Surgery, University Hospital Essen, Essen, Germany
*Purpose: Of utmost importance in living liver donation is the avoidance of postoperative complications and reduction of quality of life of the donor.*Methods: Inclusion criteria…2019 American Transplant Congress
Finding Opportunities for Increased Donation after Circulatory Death Liver Utilization: Results of an American Society of Transplant Surgeons/Association of Organ Procurement Organizations Survey
*Purpose: Liver allografts from donation after circulatory death (DCD) donors remain underutilized in the U.S. Improved utilization requires expanded potential donor identification by organ procurement…2019 American Transplant Congress
Liver Transplantation in Acute Hepatic Insufficiency Induced by Imatinib
*Purpose: Case report of a Woman, pediatrician, 40 yo,with chronic myeloid leukemia using Imatinib who developed Serious Acute Hepatic Failure and needed liver transplant to…2019 American Transplant Congress
Incisional Hernia Repair Post Liver and or Kidney Transplantation
*Purpose: The literature has demonstrated worse patient survival rates with incisional hernias in abdominal transplant patients. The purpose of this study was to evaluate patient…2019 American Transplant Congress
Rituximab Desensitization to Liver Transplantaiton Recipients with Preformed Donor Specific Antibodies to Prevent Antibody Mediated Rejecton
Transplantation Surgery, Nagoya University Hospital, Nagoya City, Japan
*Purpose: Preformed donor-specific antibodies (DSA) are considered as a risk factor after solid organ transplantation. Strong DSA is associated with high mortality and increased risk…2019 American Transplant Congress
Multicenter Experience Evaluating Outcomes of HCV-Seropositive Donors to HCV-Seronegative Recipients Liver Transplantation
*Purpose: Grafts from hepatitis C virus (HCV)-seropositive donors can now be considered for liver transplant (LT) due to the advent of direct-acting antiviral agents (DAA).…2019 American Transplant Congress
Impact of the Pediatric End-Stage Liver Disease Growth Failure Threshold on Waitlist Mortality in Children Awaiting Liver Transplant
University of California, San Francisco, San Francisco, CA
*Purpose: To examine the impact on waitlist mortality of Pediatric End-Stage Liver Disease (PELD)’s incorporation of growth failure (GF) as a threshold variable—present or absent…2019 American Transplant Congress
Viability Testing and Transplantation of Marginal Donor Livers (VITTAL) Trial: Metabolomics of Ex Vivo Normothermically Machine Perfused Livers Discloses Molecular Signatures Predictive of Graft Viability and Post Transplant Outcomes
*Purpose: Donor organ shortage has led to increased reliance on high-risk livers for transplantation. Furthermore, emergence of machine perfusion has led to a paradigm shift…2019 American Transplant Congress
Sustained Biologic Response To Neoadjuvant Therapy Predicts Excellent Liver Transplant Outcomes For Locally Advanced Intrahepatic Cholangiocarcinoma
*Purpose: Intrahepatic cholangiocarcinoma (iCCA) is a contraindication for liver transplant (LT), but prior studies limited evaluation to incidental iCCA. We recently reported significant improvement in…2019 American Transplant Congress
Expanding the Donor Pool with Extended Criteria DCD Livers
*Purpose: Utilization of extended criteria donation after circulatory death (ECD DCD) livers has remained cautious due to potentially worse outcomes because of higher rates of…
- « Previous Page
- 1
- …
- 73
- 74
- 75
- 76
- 77
- …
- 180
- Next Page »